Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Jasper Therapeutics Inc has a consensus price target of $47.57 based on the ratings of 16 analysts. The high is $90 issued by BTIG on July 8, 2024. The low is $4 issued by Credit Suisse on August 14, 2023. The 3 most-recent analyst ratings were released by JMP Securities, Evercore ISI Group, and RBC Capital on September 9, 2024, August 26, 2024, and August 14, 2024, respectively. With an average price target of $67.67 between JMP Securities, Evercore ISI Group, and RBC Capital, there's an implied 196.77% upside for Jasper Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Jasper Therapeutics (NASDAQ:JSPR) was reported by Cantor Fitzgerald on September 9, 2024. The analyst firm set a price target for $0.00 expecting JSPR to fall to within 12 months (a possible -100.00% downside). 17 analyst firms have reported ratings in the last year.
The latest analyst rating for Jasper Therapeutics (NASDAQ:JSPR) was provided by Cantor Fitzgerald, and Jasper Therapeutics reiterated their overweight rating.
There is no last upgrade for Jasper Therapeutics
There is no last downgrade for Jasper Therapeutics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Jasper Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Jasper Therapeutics was filed on September 9, 2024 so you should expect the next rating to be made available sometime around September 9, 2025.
While ratings are subjective and will change, the latest Jasper Therapeutics (JSPR) rating was a reiterated with a price target of $0.00 to $0.00. The current price Jasper Therapeutics (JSPR) is trading at is $22.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.